Unither will acquire UCB pharmaceutical plant in Rochester, New york, US.
The plant employs 250 people and mainly manufacturers liquid pharmaceutical products. This acquisition is a part of Unither's strategy to become a pharmaceutical global player and particularly in BFS technology.
The Acquisition Agreement states that Unither will continue manufacturing UCB products and all Rochester's employees will be offered the opportunity to work for Unither. While continuing manufacturing UCB products, Unither intends to install as soon as possible BFS and stick-pack technologies in Rochester's plant in order to provide its clients or US prospects with locally-made products.
The transaction is expected to be completed in the fourth quarter of this year.